Vaccine makers should license technology to overcome 'grotesque' inequity - WHO


  • World
  • Tuesday, 23 Mar 2021

FILE PHOTO: A woman holds a small bottle labelled with a "Coronavirus COVID-19 Vaccine" sticker and a medical syringe in this illustration taken October 30, 2020. REUTERS/Dado Ruvic/File Photo

GENEVA/ZURICH (Reuters) - More producers of COVID-19 vaccines should follow AstraZeneca's lead and license technology to other manufacturers, the World Health Organization's head said on Monday, as he described continuing vaccine inequity as "grotesque".

AstraZeneca's shot, which new U.S. data on Monday showed was safe and effective despite some countries suspending inoculations over health concerns, is being produced in various locations including South Korea's SKBioScience and the Serum Institute of India.

Win a prize this Mother's Day by subscribing to our annual plan now! T&C applies.

Monthly Plan

RM13.90/month

Annual Plan

RM12.33/month

Billed as RM148.00/year

1 month

Free Trial

For new subscribers only


Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
   

Next In World

UNRWA closes headquarters in E. Jerusalem after repeated attacks
UK students demonstrate Chinese proficiency in global language competition
U.S. stocks close higher
Chinese publishers stage Doha Int'l Book Fair
Trans Mountain pipeline expansion to boost Canada's crude oil export
Crude futures settle higher
U.S. dollar ticks down
Tunisia's foreign investments up 18 pct in Q1
Chinese young scientists urge global solidarity to advance sustainability agenda
Weekly storage of natural gas in U.S. increases: EIA

Others Also Read